Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-07-03T07:08:35.016Z Has data issue: false hasContentIssue false
  • English
  • Français

Remisión de los síntomas positivos de una psicosis esquizofrénica después de suprimir la lamotrigina: un informe clínico

Published online by Cambridge University Press:  12 May 2020

W. Stuve ,
A. Wessels  and
L. Timmerman
W. Stuve
Affiliation:
Adhesie, GGZ-Midden Overijssel, P. O. Box 5003, 7400GC Deventer, Países Bajos
A. Wessels
Affiliation:
Adhesie, GGZ-Midden Overijssel, P. O. Box 5003, 7400GC Deventer, Países Bajos
L. Timmerman
Affiliation:
Adhesie, GGZ-Midden Overijssel, P. O. Box 5003, 7400GC Deventer, Países Bajos
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

GlutamatoLamotriginaEsquizofrenia
Type
Caso clínico
Information
European Psychiatry (Ed. Española) , Volume 11 , Issue 3 , April 2004 , pp. 194 - 196
Copyright
Copyright © European Psychiatric Association 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Besag, F.M.C.Lamotrigine in the treatment of epilepsy in people with intellectual disability. Journal of Intellectual Disability Research 1998;42:50–6.Google ScholarPubMed
Bleich, S., Bleich, K., Wiltfang, J., Maler, M., Komhuber, J.Glutaminerge Neurotransmission bei Schizofrenien. Fortschritter der Neurologischer Psychiatrie 2001;2:S56–61 69 Sonderheft.CrossRefGoogle Scholar
Brodie, M.J.Lamotrigine. The Lancet 1992;339:1397–00.CrossRefGoogle ScholarPubMed
Cockerel, O.C., Moriarty, J., Trimble, M., Jusemir, J.W.A.S., Shorvon, S.D.Acute psychological disorders in patients with epilepsy: a nation wide study. Epilepsy Research 1996;25:119–31.CrossRefGoogle Scholar
De León, O.A., Furmaga, K.M.Effect of lamotrigine treatment in epileptic psychosis. Journal of Clinical Psychopharmacology 1999;19(2);186–7.CrossRefGoogle ScholarPubMed
Erturth, A., Walden, J., Grunze, H.Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 1999;38:204–5.CrossRefGoogle Scholar
Goff, D.C., Coyle, J.T.The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry 2001;58:1367–77.CrossRefGoogle Scholar
Kotler, M., Matar, M.A.Lamotrigine in the treatment of resistan-bipolar disorder. Clinical Neuropharmacology 1998;21:65–7.Google ScholarPubMed
Hertzberg, M.A., Butterfield, M.I., Feldman, M.E., Beckham, J.C., Sutherland, S.M., Connor, K.M., et al. A Preliminaiy study of lamotrigine for the treatment of posttraumatic stress disorder. Biological Psychiatry 1999;45:1226–9.CrossRefGoogle ScholarPubMed
Martin, M., Manos-Blanco, J.L., Lopez-Ariztegui, N.Acute psychosis inducedby lamotrigine. Epilepsia 1995;36(Suppl 3):118.Google Scholar
Mechri, A., Saoud, M., Khiari, G., d’Amato, T., Dalery, J., Gaha, L., et al. Hypothese glutaminergique de la schizophrénie: apports de recherches cliniques sur la ketamine. L’Encéphale 2001;28:53–9.Google Scholar
Polselli, G.M., Pennisi, E.M., Figa Talamanca, L., Roberti, R., Fiume Garelli, F., Bandinelli, P.L., et al. Psychotic disorder after lamotrigine. Italian Journal of Neurological Science 1998;19:124–5.CrossRefGoogle ScholarPubMed
Tascedda, F., Blom, J.M.C., Bronello, N., Zolm, K., Gennarelli, M., Colzi, A., et al. Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats. Biological Psychiatry 2001;50:117–22.CrossRefGoogle ScholarPubMed